- Home
- IKNA vs SPCB Comparison
IKNA vs SPCB Comparison
Compare IKNA & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKNA
- SPCB
- Stock Information
- Founded
- IKNA 2016
- SPCB 1988
- Country
- IKNA United States
- SPCB Israel
- Employees
- IKNA N/A
- SPCB N/A
- Industry
- IKNA Biotechnology: Pharmaceutical Preparations
- SPCB Semiconductors
- Sector
- IKNA Health Care
- SPCB Technology
- Exchange
- IKNA Nasdaq
- SPCB Nasdaq
- Market Cap
- IKNA 63.7M
- SPCB 53.3M
- IPO Year
- IKNA 2021
- SPCB N/A
- Fundamental
- Price
- IKNA $1.43
- SPCB $9.31
- Analyst Decision
- IKNA Buy
- SPCB Strong Buy
- Analyst Count
- IKNA 2
- SPCB 1
- Target Price
- IKNA $13.50
- SPCB $18.00
- AVG Volume (30 Days)
- IKNA 434.6K
- SPCB 107.5K
- Earning Date
- IKNA 07-24-2025
- SPCB 08-14-2025
- Dividend Yield
- IKNA N/A
- SPCB N/A
- EPS Growth
- IKNA N/A
- SPCB N/A
- EPS
- IKNA N/A
- SPCB 1.89
- Revenue
- IKNA N/A
- SPCB $27,831,000.00
- Revenue This Year
- IKNA N/A
- SPCB $2.73
- Revenue Next Year
- IKNA N/A
- SPCB $22.87
- P/E Ratio
- IKNA N/A
- SPCB $4.92
- Revenue Growth
- IKNA N/A
- SPCB 2.90
- 52 Week Low
- IKNA $0.97
- SPCB $2.55
- 52 Week High
- IKNA $1.94
- SPCB $18.95
- Technical
- Relative Strength Index (RSI)
- IKNA 59.83
- SPCB 42.27
- Support Level
- IKNA $1.20
- SPCB $9.36
- Resistance Level
- IKNA $1.42
- SPCB $9.70
- Average True Range (ATR)
- IKNA 0.08
- SPCB 0.58
- MACD
- IKNA 0.00
- SPCB -0.13
- Stochastic Oscillator
- IKNA 82.26
- SPCB 15.50
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.